Founder-Led 2X Daily ETF

Founder-Led 2X Daily ETF

FDRX
Founder-Led 2X Daily ETFUS flagNASDAQ Global Market
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Founder-Led 2x Daily ETF Shares (FDRX) is an exchange-traded fund that provides leveraged exposure to a proprietary index tracking founder-led U.S. companies exhibiting accelerated growth characteristics. The fund employs a daily 2x leveraged strategy through derivatives including swaps and futures, alongside direct investments in index constituents; it offers investors amplified returns tied to the performance of high-conviction equities led by founders or founder-like executives, focusing on sectors such as technology, consumer discretionary, and healthcare. Geographically, FDRX operates primarily in U.S. markets with exposure to domestic large- and mid-cap stocks; the fund was launched in 2025 and is headquartered in New York, New York, under the management of a specialized ETF provider emphasizing tactical leveraged products. Recent developments include the fund's inaugural trading debut in late 2025 amid heightened interest in founder-led investment themes, alongside a strategic partnership with a leading index provider to refine its proprietary benchmark methodology for enhanced growth factor weighting.